Synergistic effect of 5-fluorouracil and N-(phosphonacetyl)-L-aspartate on cell growth and ribonucleic acid synthesis in human mammary carcinoma.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D001943:Breast Neoplasms / Q000378:metabolism*; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D004357:Drug Synergism; D005260:Female; D005472:Fluorouracil / Q000494:pharmacology*; D006801:Humans; D009943:Organophosphorus Compounds / Q000494:pharmacology*; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000494:pharmacology*; D011061:Poly A / Q000378:metabolism; D012334:RNA, Neoplasm / Q000096:biosynthesis*; D014544:Uridine Triphosphate / Q000031:analogs & derivatives / Q000378:metabolism
D000970:Antineoplastic Agents; D009943:Organophosphorus Compounds; D012334:RNA, Neoplasm; D011061:Poly A; D001224:Aspartic Acid; C025635:5-fluorouridine 5'-triphosphate; C013195:sparfosic acid; D010746:Phosphonoacetic Acid; D005472:Fluorouracil; D014544:Uridine Triphosphate